Archean Chemical Industries Ltd (ACI) is currently trading at 479.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Archean Chemical Industries is an India‑based specialty chemicals manufacturer producing industrial salt, liquid bromine, sulphate of potash and downstream bromine derivatives from an integrated Hajipir facility with captive access to Jakhau and Mundra ports, exporting a majority of volumes and operating subsidiaries including Acume, Idealis and investments into energy and semiconductor ventures. Q1 FY27 consolidated revenue was INR3,328 million with EBITDA of INR728.7 million and consolidated PAT of INR303.5 million, while standalone PAT improved to INR405.3 million; performance showed sequential margin recovery but was materially affected by higher logistics costs, freight and certain raw material purchase variances that compressed year‑on‑year margins. Acume Chemicals, the company’s bromine derivatives arm, turned EBITDA positive in Q1 FY27 with EBITDA of INR19 million on rising volumes and a richer product mix; management reported capacity utilisation near 40% with ongoing product launches including pharma‑grade NPBR and multiple campaign products that should lift contribution margins as utilisation scales. Archean is executing a material semiconductor project (SiCSem) under a Government of India fiscal support pact with total capex ~USD249 million; management expects design readiness shortly and a construction/execution timeline of 24–27 months, with around 60–65% of project capex expected in the current financial year as the company moves into active implementation. Logistics and commodity headwinds drove near‑term margin pressure: highway construction altered haul routes increasing road distance and turnaround times, sea freight rose ~30–35%, and diesel spiked significantly in Q1; management expects these logistics inefficiencies to largely normalise by Q3 once highway works complete and fuel prices soften, improving volumes and transportation economics.

Over the past 52 weeks, Archean Chemical Industries Ltd has traded between a low of ₹446.30 and a high of ₹675.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Archean Chemical Industries Ltd has a market capitalization of approximately 5,921.68. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Archean Chemical Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 61.93 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 5,921.68 Cr, Archean Chemical Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Archean Chemical Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Archean Chemical Industries Ltd is 61.93. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Standalone income from operations was ₹315.93 crore, while consolidated income from operations was ₹327.20 crore for the quarter ended June 30, 2026.

Standalone revenue from operations was ₹3,159.3 million and standalone net profit after tax was ₹405.3 million for Q1 FY27.